Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease

OBJECTIVES: This study sought to test 2 hypotheses: 1) fibroblast growth factor (FGF)-23 identifies patients with stable ischemic heart disease (SIHD) at high risk of cardiovascular events independent of clinical factors, renal function, and established cardiovascular biomarkers; and 2) FGF-23 ident...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Udell, Jacob A., Morrow, David A., Jarolim, Petr, Sloan, Sarah, Hoffman, Elaine B., O’Donnell, Thomas F., Vora, Amit N., Omland, Torbjørn, Solomon, Scott D., Pfeffer, Marc A., Braunwald, Eugene, Sabatine, Marc S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4213068/
https://ncbi.nlm.nih.gov/pubmed/24727254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2014.03.026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados